NCT03831789

Brief Summary

Swallowing function is controlled by two swallowing centres (one on each half of the brain). There is a dominant and non-dominant swallowing centre. Damage to any part of the brain can lead to swallowing problems, for example in strokes. Recovery of the ability to swallow is associated with increased activity (compensation) over the undamaged centre. The cerebellum is an area of the brain involved in the control and modulation of muscle movements. It is found at the back of the skull. Over the past few years studies have tried to improve swallowing function using techniques to stimulate regions of the brain and encourage compensation. Repetitive transcranial magnetic stimulation (rTMS) is a technique which can temporarily increase or suppress activity over regions of the brain. This study will use cerebellar rTMS to attempt to increase activity over the cortical swallowing centres. It will also temporarily suppress activity over the dominant swallowing centre (a virtual lesion) before using cerebellar targeted rTMS to attempt to reverse this suppressive electrical and behavioural effect. The investigators aim to compare the effectiveness of rTMS over the two halves of the cerebellum to rTMS over one half of the cerebellum in increasing activity over the swallowing centres and reversing the suppressive effects of low frequency rTMS 'virtual lesion' over the dominant swallowing centre.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 8, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

June 9, 2022

Status Verified

June 1, 2022

Enrollment Period

12 months

First QC Date

February 4, 2019

Last Update Submit

June 8, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • PMEP

    Pharyngeal motor evoked potential amplitude (PMEP) amplitude

    Every 15 minutes for an hour after the intervention.

  • Swallowing behaviour

    Swallowing accuracy (number of correct swallows on target out of 10 using a swallowing reaction time task)

    Every 15 minutes for an hour after the intervention.

Study Arms (2)

Unilateral cerebellar rTMS

ACTIVE COMPARATOR
Device: Cerebellar targeted rTMS

Bilateral cerebellar rTMS

EXPERIMENTAL
Device: Cerebellar targeted rTMS

Interventions

10 Hz cerebellar rTMS (250 pulses)

Bilateral cerebellar rTMSUnilateral cerebellar rTMS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults above 18 years of age

You may not qualify if:

  • Epilepsy
  • Cardiac pacemaker
  • Previous brain surgery
  • Previous swallowing problems
  • The use of medication which acts on the central nervous system
  • Any implanted metal in the head

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Upper G.I laboratory, Salford Royal Hospital

Manchester, Greater Manchester, M6 8HD, United Kingdom

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Shaheen Hamdy

    University of Manchester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
All participants will be masked as to which of the three study arms they have been allocated. All participants over the course of three visits will either have: unilateral cerebellar rTMS or bilateral cerebellar rTMS. However, as specified earlier the order in which they will receive these interventions will be randomly allocated.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: All participants over the course of three visits will either have: unilateral cerebellar rTMS or bilateral cerebellar rTMS. However, the order in which they will receive these interventions will be randomly allocated.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 4, 2019

First Posted

February 6, 2019

Study Start

April 8, 2019

Primary Completion

March 30, 2020

Study Completion

April 30, 2020

Last Updated

June 9, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

IPD containing personal identifiable information will not be published. However, anonymised PMEP and swallowing timing data will be published.

Locations